Skip to Main Content
Date: 8 July 2019
The Department of Justice False Claims Act Policy Issue

In this second installment of Qui Tam Quarterly, K&L Gates breaks down two policy statements by the U.S. Department of Justice ("DOJ"), providing an analysis of both (1) the 2018 "Granston Memo" and related case law; as well as (2) the recent policy guidance on providing cooperation credit for self-disclosures in False Claims Act ("FCA") cases. We go beyond the press releases and sound bites to address the practical impacts of these policies and what the guidance means for practitioners and the clients they advise.

Download the newsletter

About Qui Tam Quarterly
Qui Tam Quarterly is a quarterly publication authored by members of the K&L Gates Health Care Fraud & Abuse team highlighting emerging and pressing issues in health care fraud and abuse, including litigation and governmental investigations involving the False Claims Act, the Stark Law, the Anti-Kickback Statute, and other health care fraud related statutes.

Members of our team are regular contributors to Triage: Rapid Legal Lessons for Busy Health Care Professionals, a podcast created by K&L Gates to inform our clients and friends of the firm about the latest developments in health law. Subscribe to Triage through iTunes or Google Play.

Rebecca M. Schaefer
Rebecca M. Schaefer
Research Triangle Park
View
Gabriel T. Scott
Gabriel T. Scott
Research Triangle Park
View

This publication/newsletter is for informational purposes and does not contain or convey legal advice. The information herein should not be used or relied upon in regard to any particular facts or circumstances without first consulting a lawyer. Any views expressed herein are those of the author(s) and not necessarily those of the law firm's clients.

Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel